sgpressreleases
Thursday, 19 November 2026
UNI-FUELS REGAINS COMPLIANCE WITH NASDAQ LISTING RULE
The company in a statement said it received written notification from The Nasdaq on Nov 17, confirming that it had regained compliance with Nasdaq Listing Rule 5550(a)(2) and that the matter was closed.
Uni-Fuels had received a deficiency notice on July 27, after its share price remained below the US$1.00 minimum bid price for 30 consecutive business days.
Under Nasdaq Listing Rule 5810(c)(3)(A), the company was given 180 calendar days, until Jan 25, 2027, to regain compliance.
Nasdaq determined that Uni-Fuels’ closing bid price was at least US$1.00 per share for 10 consecutive business days from Nov 3 to Nov 16, enabling the company to meet the requirement ahead of the deadline.
-- BERNAMA
NETWORK CONCERNS DELAY 72 PCT OF AI PROJECTS - OPENGEAR RESEARCH
Opengear President, Patrick Quirk said the industry has traditionally treated resilience as a response to failure, but this research showed it is also a source of business performance.
“As networks stretch across data centres, cloud, branch and edge locations, the ability to keep secure access and control over them is becoming one of the clearest measures of how well a business can operate and grow,” he added in a statement.
The research found that organisations with embedded network resilience reported average estimated outage costs around US$6 million lower over the past 12 months than those with less developed capabilities (US$12.4 million versus US$18.8 million). (US$1 = RM4.11)
Organisations with embedded resilience were also nearly twice as likely to have secure remote access and recovery capabilities in place before AI or edge deployment, with nearly all having already deployed such infrastructure, compared with about four in five organisations with less developed capabilities.
The survey covered 514 chief information officers (CIOs) and chief information security officers (CISOs) in the United States, United Kingdom, Germany, India and Australia in July and August 2026. Respondents were grouped as embedded or reactive based on their ability to remotely access and recover critical infrastructure, test recovery without the primary network and reduce reliance on sending engineers onsite.
Embedded organisations were roughly half as likely to report deployment delays of four days or more, at 21 per cent compared with 39 per cent among reactive organisations. They were also more confident in maintaining access, visibility and control during routine infrastructure changes, with 49 per cent expressing strong confidence compared with 28 per cent.
During cyber incidents, 93 per cent of embedded organisations were confident they could isolate affected systems while maintaining access to unaffected infrastructure, compared with 74 per cent of reactive organisations.
The research also found that 84 per cent of embedded organisations agreed network resilience was becoming more important as AI and edge infrastructure expanded. Supporting AI, edge or distributed infrastructure growth was also their leading investment priority for the next 12 months.
-- BERNAMA
Singapore Fintechs Lead in AI Adoption, but just 4% See Revenue Generation as Its Biggest Benefit
- Just 4% of Singapore fintechs identify new revenue generation as AI's biggest benefit, compared with 88% who cite cost reduction, risk management or employee productivity
- 86% of Singapore fintechs have deployed AI, outpacing Singapore financial institutions (65%) and global fintechs (62%)
- 94% of fintechs plan to increase their AI budgets next year, despite a gap between expected and actual returns
SINGAPORE, Nov 19 (Bernama-BUSINESS WIRE) -- Singapore's fintechs are embracing artificial intelligence (AI) at pace, but have yet to fully unlock its potential to drive business growth. While 86% have deployed AI and 94% plan to increase their AI budgets next year, just 4% identify new revenue generation as the technology's biggest benefit, a new report finds.
The Singapore FinTech Association (SFA), Airwallex and Kapronasia launched ‘The AI Inflection Point: Rewiring Fintech’ report today at the Singapore FinTech Festival 2026. Drawing on a survey of 100 fintech leaders in Singapore and in-depth interviews with 10 senior industry practitioners, the report reveals a gap between the industry's rapid AI adoption and its ability to translate that investment into business growth. Instead, fintechs see the greatest value in cost reduction (41%), risk mitigation and compliance (28%), and employee efficiency (19%).
High AI adoption, but returns remain difficult to measure
Singapore's fintechs are ahead in AI adoption, with 86% already deploying the technology, compared with 65% of Singapore financial institutions and 62% of global fintechs. However, AI integration varies considerably across business functions. While 94% report integrating AI into technology and engineering processes, only 61% report doing so in sales and marketing, highlighting opportunities to deepen its use in revenue-generating activities.
Fintechs also face challenges in measuring AI's value. While 61% expected returns of between 26% and 50% on their AI investments, only 42% reported achieving returns within that range. Meanwhile, 45% reported returns of between 1% and 25%, compared with 21% who had expected returns in that range.
Traditional return on investment (ROI) metrics may also overlook benefits such as faster product development and improved customer experiences, while revenue gains can be difficult to attribute directly to AI.
Some fintechs are already taking a different approach to measuring AI's value. Varun Mittal, Managing Director and Country Head, Keenai, said, "I see the value of AI in terms of outcomes rather than traditional ROI metrics. AI is the foundation for our core business. From a product perspective, we measure this in terms of velocity—what's the speed at which we are able to build and ship things."
Arnold Chan, General Manager, Asia Pacific, Airwallex, said, "Singapore's fintechs have been quick to embrace AI, but adoption alone doesn't translate into business value. What's important now is how effectively companies turn that investment into tangible outcomes.
"At Airwallex, we don't adopt AI for the sake of it. We focus on where it can improve efficiency, customer experiences or business growth. The next phase won't be about who deploys the most AI tools, but who can demonstrate the greatest impact."
Turning AI adoption into business growth
To unlock AI's growth potential, the report identifies three priorities for fintechs:
- Measure AI by the outcomes each function owns: Track AI's contribution through metrics such as deals closed in sales or service-level agreement (SLA) throughput in operations, rather than relying solely on broad cost and revenue figures.
- Build governance in from the start: Internal data governance remains the biggest barrier to scaling AI (63%). While 81% of fintechs are engaging with IMDA's Model AI Governance Framework and 86% with MAS's Project MindForge, only 9% have implemented controls aligned with the former, while the same proportion have established operating procedures and safeguards under the latter.
- Redesign work around AI: Rather than adding AI to existing processes, firms should rethink how work gets done and where people and AI can best complement each other to unlock greater value.
Tawishi Singh, Vice President, Singapore FinTech Association, said, "Singapore's fintech ecosystem has built a strong foundation for AI adoption, but the next phase will be about translating that momentum into meaningful and sustained business value.”
"Companies need the right skills, governance frameworks and operating models to deploy AI effectively and responsibly. SFA will continue bringing the ecosystem together, sharing practical experiences and helping fintechs move from experimentation to implementation at scale."
The full report, ‘The AI Inflection Point: Rewiring Fintech’, is available here.
Notes to editor
The ‘AI Inflection Point: Rewiring Fintech’ is a mixed-methods study by the Singapore FinTech Association, Airwallex and Kapronasia. It combined a survey of 100 fintech leaders and 10 qualitative interviews with senior practitioners, with fieldwork conducted from July to September 2026.
Respondents span Payments & Wallets (29%), WealthTech (20%), Digital Assets (13%), Banking Infrastructure & Enterprise Software (11%), Lending & Credit (8%), InsurTech (7%) and others (12%), across C-suite (13%), SVP/VP/Head of Department (54%) and Director/Senior Manager (33%) levels.
All statistics come from Kapronasia primary data, except comparisons with Singapore financial institutions and global fintechs, which draw on Finastra and NVIDIA research.
About the Singapore Fintech Association
The Singapore FinTech Association is a cross-industry non-profit organisation. Its purpose is to support the development of the FinTech industry in Singapore and facilitate collaboration among the participants and stakeholders. The SFA is a member-based organisation with over 600+ members. It represents the full range of stakeholders in the FinTech industry, from early-stage innovative companies to large financial players and service providers.
To further its purpose, the SFA also partners with institutions and associations from Singapore and globally to cooperate on initiatives relating to the FinTech industry. Well-connected globally, the SFA has signed over 70 international Memorandum of Understanding (MoU) to lay the network for its members and ecosystem.
About Airwallex
Airwallex is an AI native financial operating system for modern businesses. We are building the future of global banking for a borderless, real-time, intelligent economy.
We serve more than 676,000 businesses worldwide, either directly or through our platform customers. From startups to public enterprises, our customers use Airwallex to manage their global banking and financial operations, or to build and monetise their own financial products.
Founded in Melbourne in 2015, Airwallex holds 85+ licenses across North America, Europe, the Middle East, and Asia-Pacific, forming one of the most comprehensive financial infrastructures in the world. This regulated backbone powers Airwallex products at global scale, including payment acceptance, billing, global accounts, corporate cards, and spend management.
The company is co-headquartered in San Francisco and Singapore with over 2,600 employees across 27 offices. Learn more at www.airwallex.com.
About Kapronasia
Kapronasia, an Atlas Technologies Group Company, is a leading consulting and market research firm specializing in fintech, banking, payments, and capital markets. Our services aim to equip clients across the region with the necessary insights to capitalize on their most valuable opportunities and maintain a competitive edge in the market.
For more information, please visit sg.atlstech.com
View source version on businesswire.com:
https://www.businesswire.com/news/home/20261118285416/en/
Contact
Media Contact
RICE, A Finn Partners Company for Airwallex
airwallex@finnpartners.com
Source : Airwallex
Wednesday, 18 November 2026
AM BEST: CHINA REINSURANCE PILOT TO OPEN OVERSEAS GROWTH OPPORTUNITIES
KUALA LUMPUR, Nov 18 (Bernama) -- An investment pilot programme in China allowing greater overseas investment of inward cross-border reinsurance income is credit positive, as it could create new growth opportunities beyond the competitive domestic non-life insurance market, according to AM Best.
The policy document was jointly released by the Office of the Financial Commission of the CPC Shanghai Municipal Committee, the Shanghai branch of the National Financial Regulatory Administration, the People's Bank of China Shanghai Head Office and the Shanghai branch of the State Administration of Foreign Exchange.
It covers four selected insurers, namely PICC Property and Casualty, Ping An Property Insurance, China Pacific Property Insurance and China Property & Casualty Reinsurance, allowing them to invest inward cross-border reinsurance revenue in overseas markets through the Shanghai International Reinsurance Centre, subject to a dedicated investment quota of US$1 billion. (US$1 = RM4.09)
According to AM Best's commentary, the pilot could improve insurers' business profiles through geographical and revenue diversification, while enabling them to better match overseas assets and liabilities by linking offshore underwriting with offshore investment, thereby improving the commercial sustainability of China's cross-border reinsurance business.
“Despite China’s sizeable overseas footprint, the participation of Chinese insurers remains very low, and so the Shanghai pilot provides an important new channel for Chinese insurers to support Chinese Interests Abroad and the Belt and Road Initiative-related business,” said AM Best financial analyst, Aaron Li in a statement.
The commentary said further expansion of the pilot should support Shanghai's development as an international reinsurance hub. Officially launched around three years ago, the Shanghai International Reinsurance Centre remains at an early stage of development.
AM Best said overseas institutions account for more than one-third of the institutions based at the centre, compared with other markets such as London and Singapore, where approximately 70 per cent of premiums come from overseas, and Hong Kong, which derives approximately 45 per cent of its premiums from overseas.
Further development of the platform could help accelerate the inflow of global risks into Shanghai, added the credit rating agency.
“The US$1 billion initial quota in the pilot programme is modest, making the pilot more significant as a structural policy development and controlled testing ground than as an immediate driver of premium or investment growth,” said AM Best associate director, Lucie Huang.
-- BERNAMA
H2O.AI LAUNCHES TWO NEW PREDICTIVE AI FOUNDATION MODELS
KUALA LUMPUR, Nov 18 (Bernama) -- H2O.ai has launched the next version of its predictive artificial intelligence (AI) capabilities, adding two new foundation models, TimeH2O for time-series data and TabH2O for tabular data.
TimeH2O is a 108-million-parameter time-series foundation model that makes zero-shot forecasts, allowing it to predict outcomes using data it has never encountered without requiring a separate model for each dataset. Organisations can fine-tune it using their own data for demand forecasting, inventory and financial planning.
Meanwhile, TabH2O, a tabular foundation model, supports predictions using structured business data for applications such as risk scoring, fraud detection and customer analytics. Both models join H2O Driverless AI, an automated machine learning (AutoML) tool, in the company's predictive AI capabilities.
According to H2O.ai in a statement, most organisational decisions involve time-series and tabular data, including demand, inventory, cash flow, risk and fraud, with each forecast or prediction previously requiring a separate model to be built and maintained.
TimeH2O-v1 ranked first among 32 models on the fev-bench forecasting leaderboard as of Oct 23, with a 91.9 per cent win rate, despite not being trained on any fev-bench dataset.
H2O MLOps, a model deployment and monitoring tool, enables organisations to deploy TimeH2O and TabH2O on H2O AI Cloud, fine-tune them using their own data and manage their entire model lifecycle with built-in monitoring and audit capabilities.
Organisations can also choose their deployment environments through H2O AI Managed Cloud, operated by H2O.ai; H2O AI Hybrid Cloud, which supports private cloud, on-premises and air-gapped environments; or H2O AI Cloud for Government, which is FedRAMP High certified.
TimeH2O and TabH2O are now generally available on H2O AI Cloud for production use and fine-tuning using organisations' own data. However, production use of TimeH2O-v1's open weights requires a licence from H2O.ai.
-- BERNAMA
Monday, 16 November 2026
TAIWAN’S FUBON INSURANCE CREDIT RATINGS AFFIRMED, OUTLOOK STABLE
The credit ratings (ratings) reflect Fubon Insurance’s very strong balance sheet strength, adequate operating performance, favourable business profile and appropriate enterprise risk management, according to AM Best.
The credit rating agency upgraded its assessment of Fubon Insurance's balance sheet strength to very strong from strong, citing improved risk-adjusted capitalisation, as measured by Best's Capital Adequacy Ratio.
In a statement, AM Best said the company's consolidated capital and surplus grew at a double-digit rate in 2025 and continued to increase in the first half of 2026, reaching TWD39.5 billion (TWD100 = RM12.40)
The improvement was supported by the retention of positive underwriting and investment results, while pandemic-related reinsurance recoverables were fully settled in late 2025. Uncertainty surrounding deferred tax assets arising from pandemic-related insurance losses had also largely eased, although the company's risk-adjusted capitalisation remained below pre-pandemic levels.
Other supporting factors include a diversified investment portfolio focused on low-risk fixed-income securities, comprehensive reinsurance arrangements, adequate liquidity and long-term capital support from its parent, Fubon Financial Holding Co Ltd.
Fubon Insurance reported a net profit of TWD7.4 billion in 2025, while gross premiums written grew at a mid-single-digit rate, mainly driven by expansion in its motor and engineering businesses. Its combined ratio improved to 88.5 per cent, supported by favourable claims experience and a lower expense ratio.
The company also recorded a net profit of TWD5.7 billion in the first half of 2026, attributed to favourable underwriting performance and investment gains from capital appreciation. Fubon Insurance maintained its leading position in Taiwan's non-life insurance market, with a 24.6 per cent share of direct premiums written in the first nine months of 2026.
-- BERNAMA
SBC Medical Announces Capital and Business Alliance with NeuroBrain Dynamics to Advance Clinic Profitability Through Medical AI
IRVINE, Calif., Nov 16 (Bernama-BUSINESS WIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced a strategic capital and business alliance agreement with NeuroBrain Dynamics Inc. (“NBD”), a Taipei-based company dedicated to enterprise generative AI solutions. As part of the agreement executed on November 13, 2026, SBC Medical has made a minority equity investment in NBD.
Through this alliance, SBC Medical plans to introduce two complementary suites of generative AI solutions across its network of 287 clinics in Japan and overseas*: “revenue-growth AI,” to elevate average revenue per visit and customer retention through personalized customer guidance, and “cost-reduction AI,” to streamline medical documentation, staff scheduling, and promotional workflows. These initiatives are designed to improve per-clinic profitability.
Furthermore, SBC Medical has secured priority sales rights for NBD’s existing products in Japan and South Korea. The Company plans to offer these proven solutions to external medical institutions, establishing a high-margin business-to-business (B2B) revenue stream and accelerating its expansion into broader Asian markets alongside NBD.
Key Points of the Alliance
- Accelerating Top-Line Revenue Growth: Utilizing NBD’s enterprise AI platform “Argon,” the companies will develop and deploy an AI-powered concierge guidance tool and a history-based predictive recommendation feature for SBC Medical’s “MySBC” booking system to maximize customer lifetime value (LTV).
- Optimizing Operational Margin: Generative AI will assist with routine clinical documentation, optimize staff scheduling, and generate compliant marketing materials (with final review by physicians and staff). With reduced administrative burdens, physicians and clinic staff can redirect critical hours toward high-value medical care and customer service.
- Establishing a Standardized Foundation for Scale: The jointly developed AI platform will serve as the standardized operating foundation for SBC Medical’s next growth phase, driving rapid clinic deployments across Japan via organic openings and M&A. The solutions will be built primarily on a sovereign Large Language Model (LLM) platform designed to strengthen data privacy and compliance.
With a footprint of 287 clinics, minor operational efficiencies could yield substantial margin improvements across the entire Group. The alliance focuses on the development and deployment of six core solutions.
Revenue Growth & Retention
1. AI Concierge Guidance Support Tool: Analyzes each customer’s visit and treatment history and instantly displays on the concierge’s screen the information needed to assist the customer. The tool helps reduce variations in the quality of guidance arising from differences in staff experience, enabling customers to receive accurate information promptly and supporting higher average revenue per visit for the Company across all 287 clinics. (Note: All clinical decisions remain strictly under physician discretion.)
2. History-Based Recommendation Feature for “MySBC”: Delivers personalized, non-intrusive follow-up suggestions within the MySBC booking system based on each customer’s usage history, driving recurring appointments without additional user acquisition costs.
Solutions 1 and 2 will be co-developed based on NBD’s existing AI platform, Argon.
Productivity & Margin Improvement
3. AI-Assisted Electronic Medical Records (EMR): Converts patient-doctor consultation dialogue into structured SOAP (Subjective, Objective, Assessment, Plan) formatted drafts using speech recognition. This expands physician daily patient capacity while minimizing clerical burnout. Verification will begin in orthopedics, with accuracy testing scheduled for completion via a proof of concept (PoC) by year-end 2026.
4. AI Smart Shift Scheduling: Automates complex shift scheduling for physicians and nurses by mapping customer demand against labor laws and regulations, clinic rules, and the procedures each physician is able to perform. This eliminates manual management overhead and optimizes labor cost efficiency during peak clinic hours.
5. Clinic Promotion Planner (CPP): Automatically generates compliant promotional images for social media based on the specified treatments, services, and key messages, with built-in automated checks against internal guidelines, drastically reducing outsourcing dependencies and marketing cycle times.
Infrastructure and Security
6. Sovereign LLM and “Bromine” Security Monitoring: The solutions are built primarily on SBC Medical’s secure, sovereign LLM infrastructure to protect customer confidentiality. NBD’s proprietary security product, Bromine, will continuously monitor AI inputs and detect potential data leakage risks, providing enterprise-grade governance.
Synergies and Partner Selection
The deployment architecture enables an asset-light international expansion model. Local operating partners across Asia will provide the physical capital and operational management, while SBC Medical and NBD deliver the core technological foundation and clinical workflows.
Founded in Taiwan in June 2024, NBD has successfully deployed enterprise AI systems across more than 100 companies in the Asia-Pacific region, including multi-site operators such as a major convenience store chain, mass retailers, and railway and airline companies. NBD’s rapid operational scaling, expanding to seven strategic hub cities (Taipei, Hong Kong, Bangkok, Manila, Ho Chi Minh City, Kuala Lumpur, and Jakarta) within approximately two years, supports its capability to anchor SBC Medical’s international growth roadmap.
Outlook
The Company will systematically validate each AI module, with rollout for the AI Concierge Guidance Support Tool, the MySBC history-based recommendation feature, and CPP scheduled across the clinic network starting mid-2027. Concurrently, the Company will launch commercial outreach to market these systems to third-party medical institutions, while advancing B2B expansion in Asia.
Comments
Yoshiyuki Aikawa, CEO, SBC Medical Group Holdings Incorporated
“This alliance represents the next structural evolution of our MSO platform. Across a 287-clinic network, even micro efficiencies scale into significant potential earnings power. By blending SBC Medical’s deep, on-the-ground operational data with NeuroBrain Dynamics’ proven enterprise AI execution, we are positioning our business to achieve improved operating leverage while delivering exceptional value to our customers, clinic partners, and shareholders.”
Jeff Chuang, Chairman and CEO, NeuroBrain Dynamics Inc.
“We are truly honored to enter into this capital and business alliance with SBC Medical. Since our founding, NBD has built a distinctive ‘AI VDE (value delivery)’ culture that brings together forward deployed engineers (FDE), our research and development (R&D) team, and finance, and we have pursued AI implementation that delivers tangible value and ROI to businesses. The healthcare industry, where AI adoption is now gaining real momentum, is the field in which the reliability and effectiveness of AI are tested most rigorously. With our proprietary AI platforms Argon and Bromine at the core, we will work with SBC Medical to build medical AI solutions that achieve both safety and profitability, and bring them to Japan, South Korea, and markets across Asia.”
Overview of the Capital and Business Alliance
Partner: NeuroBrain Dynamics Inc. (創智動能股份有限公司)
Agreement date: November 13, 2026
Scope of the business alliance: Joint development of AI solutions for the SBC Medical Group; collaboration on deployment in Japan and South Korea; priority sales rights to distribute NBD’s existing products (including Bromine and Argon) in Japan and South Korea; and exclusive use of the jointly developed solutions in those regions
Capital alliance: Minority equity investment in NBD by SBC Medical
About NeuroBrain Dynamics Inc.
Company name: NeuroBrain Dynamics Inc. (創智動能股份有限公司)
Founded: June 2024
Location: 9F., No. 23, Sec. 1, Bade Rd., Zhongzheng Dist., Taipei City 100410, Taiwan
Representative: Jeff Chuang, Chairman
Business: AI implementation consulting and development for enterprises; provision of AI SaaS/PaaS
Website: https://nbd-ai.com/
| *As of the end of July 2026. |
| Note: The investment amount, shareholding ratio, and other details have not been disclosed. |
| Note: The initiatives under this alliance are based on current plans and are subject to change. |
About SBC Medical Group Holdings Incorporated
SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s plans and strategies for service expansion; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20261113869539/en/
Contact
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp
Source : SBC Medical Group Holdings Incorporated